Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 10, 2023

Incidence and Time to Resolution of Eribulin-Induced Peripheral Neuropathy in Patients With Locally Advanced or Metastatic Breast Cancer

The Oncologist


Additional Info

The Oncologist
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE) in Locally Advanced or Metastatic Breast Cancer: Prospective Cohort Study
Oncologist 2023 Aug 09;[EPub Ahead of Print], HJ Lück, M Schmidt, T Hesse, O Hoffmann, BJ Heinrich, TW Park-Simon, EM Grischke, R Weide, H Müller-Huesmann, K Lüdtke-Heckenkamp, D Fischer, C Zemlin, M Kögel, J Wu, H Schmitz, C Engelbrecht, C Jackisch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading